197 related articles for article (PubMed ID: 20569464)
1. Deletion analysis of BMI1 oncoprotein identifies its negative regulatory domain.
Yadav AK; Sahasrabuddhe AA; Dimri M; Bommi PV; Sainger R; Dimri GP
Mol Cancer; 2010 Jun; 9():158. PubMed ID: 20569464
[TBL] [Abstract][Full Text] [Related]
2. The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors.
Bommi PV; Dimri M; Sahasrabuddhe AA; Khandekar J; Dimri GP
Cell Cycle; 2010 Jul; 9(13):2663-73. PubMed ID: 20543557
[TBL] [Abstract][Full Text] [Related]
3. βTrCP regulates BMI1 protein turnover via ubiquitination and degradation.
Sahasrabuddhe AA; Dimri M; Bommi PV; Dimri GP
Cell Cycle; 2011 Apr; 10(8):1322-30. PubMed ID: 21430439
[TBL] [Abstract][Full Text] [Related]
4. Bmi1 regulates stem cells and proliferation and differentiation of committed cells in mammary epithelium.
Pietersen AM; Evers B; Prasad AA; Tanger E; Cornelissen-Steijger P; Jonkers J; van Lohuizen M
Curr Biol; 2008 Jul; 18(14):1094-9. PubMed ID: 18635350
[TBL] [Abstract][Full Text] [Related]
5. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
[TBL] [Abstract][Full Text] [Related]
6. BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases.
Hoenerhoff MJ; Chu I; Barkan D; Liu ZY; Datta S; Dimri GP; Green JE
Oncogene; 2009 Aug; 28(34):3022-32. PubMed ID: 19543317
[TBL] [Abstract][Full Text] [Related]
7. Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences.
Siddique HR; Saleem M
Stem Cells; 2012 Mar; 30(3):372-8. PubMed ID: 22252887
[TBL] [Abstract][Full Text] [Related]
8. Sonic hedgehog regulates Bmi1 in human medulloblastoma brain tumor-initiating cells.
Wang X; Venugopal C; Manoranjan B; McFarlane N; O'Farrell E; Nolte S; Gunnarsson T; Hollenberg R; Kwiecien J; Northcott P; Taylor MD; Hawkins C; Singh SK
Oncogene; 2012 Jan; 31(2):187-99. PubMed ID: 21685941
[TBL] [Abstract][Full Text] [Related]
9. BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer.
Zhang XW; Sheng YP; Li Q; Qin W; Lu YW; Cheng YF; Liu BY; Zhang FC; Li J; Dimri GP; Guo WJ
Mol Cancer; 2010 Feb; 9():40. PubMed ID: 20170541
[TBL] [Abstract][Full Text] [Related]
10. Polycomb group protein Bmi1 promotes hematopoietic cell development from embryonic stem cells.
Ding X; Lin Q; Ensenat-Waser R; Rose-John S; Zenke M
Stem Cells Dev; 2012 Jan; 21(1):121-32. PubMed ID: 21545235
[TBL] [Abstract][Full Text] [Related]
11. Functional antagonism of the Polycomb-Group genes eed and Bmi1 in hemopoietic cell proliferation.
Lessard J; Schumacher A; Thorsteinsdottir U; van Lohuizen M; Magnuson T; Sauvageau G
Genes Dev; 1999 Oct; 13(20):2691-703. PubMed ID: 10541555
[TBL] [Abstract][Full Text] [Related]
12. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma.
Chiba T; Miyagi S; Saraya A; Aoki R; Seki A; Morita Y; Yonemitsu Y; Yokosuka O; Taniguchi H; Nakauchi H; Iwama A
Cancer Res; 2008 Oct; 68(19):7742-9. PubMed ID: 18829528
[TBL] [Abstract][Full Text] [Related]
13. Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death.
Liu L; Andrews LG; Tollefsbol TO
Oncogene; 2006 Jul; 25(31):4370-5. PubMed ID: 16501599
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of interactions between the vertebrate polycomb-group protein BMI1 and human homologs of polyhomeotic.
Gunster MJ; Satijn DP; Hamer KM; den Blaauwen JL; de Bruijn D; Alkema MJ; van Lohuizen M; van Driel R; Otte AP
Mol Cell Biol; 1997 Apr; 17(4):2326-35. PubMed ID: 9121482
[TBL] [Abstract][Full Text] [Related]
15. Direct activation of Bmi1 by Twist1: implications in cancer stemness, epithelial-mesenchymal transition, and clinical significance.
Wu KJ
Chang Gung Med J; 2011; 34(3):229-38. PubMed ID: 21733352
[TBL] [Abstract][Full Text] [Related]
16. Structure and E3-ligase activity of the Ring-Ring complex of polycomb proteins Bmi1 and Ring1b.
Buchwald G; van der Stoop P; Weichenrieder O; Perrakis A; van Lohuizen M; Sixma TK
EMBO J; 2006 Jun; 25(11):2465-74. PubMed ID: 16710298
[TBL] [Abstract][Full Text] [Related]
17. Role of the polycomb group gene BMI1 in normal and leukemic hematopoietic stem and progenitor cells.
Schuringa JJ; Vellenga E
Curr Opin Hematol; 2010 Jul; 17(4):294-9. PubMed ID: 20308890
[TBL] [Abstract][Full Text] [Related]
18. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.
van Leenders GJ; Dukers D; Hessels D; van den Kieboom SW; Hulsbergen CA; Witjes JA; Otte AP; Meijer CJ; Raaphorst FM
Eur Urol; 2007 Aug; 52(2):455-63. PubMed ID: 17134822
[TBL] [Abstract][Full Text] [Related]
19. E4F1: a novel candidate factor for mediating BMI1 function in primitive hematopoietic cells.
Chagraoui J; Niessen SL; Lessard J; Girard S; Coulombe P; Sauvageau M; Meloche S; Sauvageau G
Genes Dev; 2006 Aug; 20(15):2110-20. PubMed ID: 16882984
[TBL] [Abstract][Full Text] [Related]
20. Timosaponin A-III inhibits oncogenic phenotype via regulation of PcG protein BMI1 in breast cancer cells.
Gergely JE; Dorsey AE; Dimri GP; Dimri M
Mol Carcinog; 2018 Jul; 57(7):831-841. PubMed ID: 29528145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
